A multicentre evaluation of the laser assisted ratio analyser (LARA): A novel device for measurement of (CO2)-C-13 in the C-13-urea breath test for the detection of Helicobacter pylori infection
Dr. Cave et al., A multicentre evaluation of the laser assisted ratio analyser (LARA): A novel device for measurement of (CO2)-C-13 in the C-13-urea breath test for the detection of Helicobacter pylori infection, ALIM PHARM, 13(6), 1999, pp. 747-752
Background: The laser assisted ratio analyser (LARA) was developed as a nov
el device to measure (CO2)-C-13 in the urea breath test for the detection o
f H. pylori infection. The analyser was tested in a prospective multicentre
study in 444 patients in North America (Phase 1) followed by second study
involving 160 patients (Phase 2).
Methods: Patients undergoing endoscopy for clinical indications had antral
and gastric biopsies taken for histological examination, culture and CLO te
st. One hour after endoscopy, a baseline breath sample was obtained, 100 mg
of C-13-urea were ingested and breath samples were obtained at 30 and 60 m
in post ingestion. Data obtained with the LARA were compared with the resul
ts of culture, rapid urease testing and central pathology in two different
combinations {reference standards}. The study was conducted in two phases:
in Phase 2, a modification was made to the LARA that improved the removal o
f water vapour from the breath sample.
Results: In Phase I, data from 331 patients were analysed using a cut off o
f (delta) 7.8 +/- 0.8, the sensitivity of the method was 91.7% and the spec
ificity was 86.5%, using the reference standard of 2 of 3 tests (CLO, cultu
re or histology) being positive. Positive and negative predictive values we
re, respectively, 85.2% and 92.5%. In Phase 2 of the study, 160 patients we
re enrolled and 141 patients were analysed using the same standards. We use
d the same reference standards but with a cut off of (delta) 6.1 +/- 0.6. T
he sensitivity and specificity increased to 96.8% and 98.6%, respectively.
Positive and negative predictive values were, respectively, 98.4% and 97.3%
. The detection rates for H. pylori were similar in patients with peptic ul
cer or H. pylori associated gastritis.
Conclusions: The LARA provides an accurate noninvasive means of detecting (
CO2)-C-13 in the C-13-urea breath test for H. pylori in a multicentre clini
cal environment that compares well with invasive 'gold standard' methods.